INTERNATIONAL PATENT: SUZHOU GENEPHARMA CO., LTD., 苏州吉玛基因股份有限公司 FILES APPLICATION FOR "ANGIOTENSINOGEN-TARGETING DOUBLE-STRANDED RNA MOLECULE, MODIFIER THEREOF AND USE THEREOF"

GENEVA, Feb. 8 -- SUZHOU GENEPHARMA CO., LTD. (No. 199, Dongping Street, Suzhou Industrial ParkSuzhou, Jiangsu 215123), 苏州吉玛基因股份有限公司 (中国江苏省苏州市工业园区东平街199号) filed a patent application (PCT/CN2025/111389) for "ANGIOTENSINOGEN-TARGETING DOUBLE-STRANDED RNA MOLECULE, MODIFIER THEREOF AND USE THEREOF" on Jul 30, 2025. With publication no. WO/2026/026829, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...